A method for producing an amidate compound represented by Formula (4), comprising reacting an iminium salt represented by Formula (1) and an organic compound represented by Formula (3), wherein Formulas (1), (3), and (4) are as defined in the description.

A small crystal size, high surface area aluminogermanosilicate molecular sieve material, designated SSZ-120, is provided. SSZ-120 can be synthesized using 3,3′-[2,6-naphthalenebis(methylene)]bis[1,2-dimethyl-1H-imidazolium] dications as a structure directing agent. SSZ-120 may be used in organic compound conversion reactions and/or sorptive processes.

The invention provides: imidazole and imidazolium compounds of formulas (I) and (II): ##STR00001##
polymers containing a plurality of imidazolium-containing repeating units of formula (III′): ##STR00002##
and membranes and devices comprising the polymers. Also provided are methods of making the inventive compounds and polymers.

The invention provides: imidazole and imidazolium compounds of formulas (I) and (II): ##STR00001##
polymers containing a plurality of imidazolium-containing repeating units of formula (III′): ##STR00002##
and membranes and devices comprising the polymers. Also provided are methods of making the inventive compounds and polymers.

An ordered macroporous metal-organic framework single crystals and a preparation method therefor. In the method, a three-dimensional structure constructed by polymer microspheres is used as a template; 2-methylimidazole and zinc nitrate, precursors of MOFs, are firstly deposited in the three-dimensional template; the three-dimensional template containing the precursors is soaked in a mixed solution of ammonia water and methanol subsequently, and the three-dimensional template is taken out after crystallization; the three-dimensional template is soaked in an organic solvent to remove the macromolecular three-dimensional template, and the ordered macroporous MOF single crystals is obtained through centrifugal separation. The ordered macroporous MOF single crystals have a basic framework of zeolitic imidazolate framework-8, and structurally include highly-ordered macro-pores whose pore size may be controlled to be between 50 and 2000 nm based on a size of the used template.

An ordered macroporous metal-organic framework single crystals and a preparation method therefor. In the method, a three-dimensional structure constructed by polymer microspheres is used as a template; 2-methylimidazole and zinc nitrate, precursors of MOFs, are firstly deposited in the three-dimensional template; the three-dimensional template containing the precursors is soaked in a mixed solution of ammonia water and methanol subsequently, and the three-dimensional template is taken out after crystallization; the three-dimensional template is soaked in an organic solvent to remove the macromolecular three-dimensional template, and the ordered macroporous MOF single crystals is obtained through centrifugal separation. The ordered macroporous MOF single crystals have a basic framework of zeolitic imidazolate framework-8, and structurally include highly-ordered macro-pores whose pore size may be controlled to be between 50 and 2000 nm based on a size of the used template.

The present invention disclose a single step one pot process for synthesis of oxazoline and imidazole derivatives from glycerol using solid acid metal catalyst with improved yield.

The present invention disclose a single step one pot process for synthesis of oxazoline and imidazole derivatives from glycerol using solid acid metal catalyst with improved yield.

The present invention relates to a compound of the Formula I:

##STR00001##

and a lubricating composition containing and a method for preparing the same. In Formula I, R.sub.1-R.sub.5 and R.sub.6-R.sub.10 are independently selected from the group consisting of hydrogen, hydrocarbyl groups and hydrocarbyl groups containing heteroatoms, such that the total carbon atoms from Q.sub.1 and Q.sub.2 is from 6 to 166 carbon atoms, and molybdate anion (Y) is a binuclear sulfur-containing dianion selected from the group consisting of [Mo.sub.2S.sub.8O.sub.2].sup.2−, [Mo.sub.2S.sub.9O].sup.2−, and [Mo.sub.2S.sub.10].sup.2.

The subject matter of the present invention is novel families of compounds which are aromatic amine, imine, aminoadamantane and benzodiazepine derivatives, medicaments comprising same and the use thereof as inhibitors of the toxic effects of toxins with intracellular activity, such as, for example, ricin, and of viruses that use the internalization pathway for infecting cells.